# EDGAR Filing Document

**Accession Number:** 0001609765
**File Stem:** 0001243786-23-000032
**Filing Date:** 2023-3
**Character Count:** 9872
**Document Hash:** f09b9e4cf5d7707452820db657709bac
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001243786-23-000032.hdr.sgml**: 20230308

**ACCESSION NUMBER**: 0001243786-23-000032

**CONFORMED SUBMISSION TYPE**: 4/A

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230305

**FILED AS OF DATE**: 20230308

**DATE AS OF CHANGE**: 20230308

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Precourt Walter F. III
- **CENTRAL INDEX KEY:** 0001609765

**FILING VALUES:**
- **FORM TYPE:** 4/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-32327
- **FILM NUMBER:** 23716693

**MAIL ADDRESS:**
- **STREET 1:** C/O THE MOSAIC COMPANY
- **STREET 2:** 101 EAST KENNEDY BLVD., SUITE 2500
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33602
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MOSAIC CO
- **CENTRAL INDEX KEY:** 0001285785
- **STANDARD INDUSTRIAL CLASSIFICATION:** AGRICULTURE CHEMICALS [2870]
- **IRS NUMBER:** 201026454
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 101 EAST KENNEDY BLVD.
- **STREET 2:** SUITE 2500
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33602
- **BUSINESS PHONE:** 813-775-4200

**MAIL ADDRESS:**
- **STREET 1:** 101 EAST KENNEDY BLVD.
- **STREET 2:** SUITE 2500
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33602

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GLOBAL NUTRITION SOLUTIONS INC
- **DATE OF NAME CHANGE:** 20040401

## Ex-24

POWER OF ATTORNEY

Know all by these presents, that I hereby constitute and appoint each of Philip E. Bauer and Beth A. Paulson my true and lawful attorney-in-fact and agent, each acting alone, with full power of substitution for me and in my name, place and stead, to:

1.&nbsp;&nbsp;&nbsp;&nbsp;execute for me and on my behalf, in my capacity as an officer, director and/or 10% shareholder of The Mosaic Company, Forms 3, 4 or 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, or any rule or regulation of the United States Securities and Exchange Commission ('SEC");

2.&nbsp;&nbsp;&nbsp;&nbsp;do and perform any and all acts for me and on my behalf which may be necessary or desirable to complete and execute any such Form 3, 4 or 5, or other form or report, complete and execute any amendment or amendments thereto and timely file such form or report with the SEC and any stock exchange or similar authority; and

3.&nbsp;&nbsp;&nbsp;&nbsp;take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to me, in my best interest or legally required by me, it being understood that the documents executed by such attorney-in-fact on my behalf pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

I hereby grant to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as I might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. I acknowledge that the attorneys-in-fact, in serving in such capacity at my request, are not assuming, nor is The Mosaic Company assuming, any of my responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended.

This Power of Attorney shall remain in full force and effect until I am no longer required to file Forms 3, 4 and 5 with respect to my holdings of and transactions in securities of The Mosaic Company, unless earlier revoked by me in a signed writing delivered to the attorneys-in-fact named above and shall supersede and all other previous and prior powers of attorney granted by me in my capacity as an officer, director and/or 10% shareholder of The Mosaic Company and relating to my responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended, if any, all of which are hereby deemed to be revoked .

IN WITNESS WHEREOF, I have signed this Power of Attorney on January 4, 2023.

<u>/s/ Walter F. Precourt III&nbsp;&nbsp;&nbsp;&nbsp;</u>

Signature

<u>Walter F. Precourt, III&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

Printed Name

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4/A

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Precourt Walter F. III<br><sub>(Last) (First) (Middle)</sub><br>C/O THE MOSAIC COMPANY<br>101 EAST KENNEDY BLVD., SUITE 2500<br><sub>(Street)</sub><br>TAMPA, FL 33602<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-05 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Senior VP - Strategy & Growth_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>MOSAIC CO [ MOS ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2023-03-05 |  | M |  | 24707 | A | $0 | 44707 | D |  |
| Common Stock | 2023-03-05 |  | M<sup>(1)</sup> |  | 103489 | A | $0 | 148196 | D<sup>(2)</sup> |  |
| Common Stock | 2023-03-05 |  | F<sup>(3)</sup> |  | 50512 | D | $57.14 | 97684 | D<sup>(2)</sup> |  |
| Common Stock |  |  |  |  |  |  |  | 55000<sup>(4)</sup> | I | By 2022 GRAT dated August 1, 2022 |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | 0.0<sup>(5)</sup> | 2023-03-05 |  | M |  |  | 24707 | 2023-03-05 | <sup>(6)</sup> | Common Stock | 24707.0 | $0 | 0 | D |  |

---

### Footnotes:

(1) Shares issued to reporting person upon the vesting of a performance unit award granted to reporting person on March 5, 2020.  The performance unit award was not a derivative security.

(2) The ownership form has been corrected to reflect "direct" ownership rather than "indirect" ownership.

(3) Shares sold to cover tax liability incurred as a result of most recent vesting of restricted stock and performance units.

(4) The number of shares held, indirectly, by the reporting person has been adjusted following the reclassification of the previously reported transactions.

(5) One-for-One

(6) Not Applicable

**Signature:** /s/ Philip E. Bauer, Attorney-in-Fact for Walter F. Precourt III  
**Date:** 2023-03-08

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**